AN2 Therapeutics, Inc. (NASDAQ:ANTX) IPO

AN2 Therapeutics, Inc.

IPO

Priced at US$15.00 a share on Mar 24, 2022.

Price
US$15.00 a share
Shares offered
4,600,000 shares of common stock
Offering size
US$69 million
Underwriters' option
Up to 690,000 more shares
Underwriters
Cowen, SVB Leerink, Evercore ISI, Oppenheimer & Co. · In the order on the cover

Steps

StepWhen
Draft sent to the SEC in confidenceSep 24, 2021
Filed publiclyMar 4, 2022
Amended onceMar 21, 2022
Shares registered with an exchangeMar 22, 2022
Declared effective by the SECMar 24, 2022
Final prospectus, with the priceMar 28, 2022

From the cover of the final prospectus (424B4) filed Mar 28, 2022